Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease
Selina Khan(Zero to Three), Jerome Custers(Janssen (Netherlands))
Cited by 26
Related Papers
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
|New England Journal of Medicine|2022|250
Distinct Uptake Mechanisms but Similar Intracellular Processing of Two Different Toll-like Receptor Ligand-Peptide Conjugates in Dendritic Cells
|Journal of Biological Chemistry|2007|173